158 related articles for article (PubMed ID: 37608980)
1. A review of China's compensation program for adverse reactions following immunization.
Yingxiong W
Front Public Health; 2023; 11():1211976. PubMed ID: 37608980
[TBL] [Abstract][Full Text] [Related]
2. Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries.
Mungwira RG; Maure CG; Zuber PLF
Vaccine; 2019 Jul; 37(31):4370-4375. PubMed ID: 31213377
[TBL] [Abstract][Full Text] [Related]
3. No-Fault Compensation for Adverse Events Following Immunization: A Review of Chinese Law And Practice.
Fei L; Peng Z
Med Law Rev; 2017 Feb; 25(1):99-114. PubMed ID: 28177508
[TBL] [Abstract][Full Text] [Related]
4. Vaccine injury compensation: the Israeli case.
Kamin-Friedman S; Davidovitch N
Isr J Health Policy Res; 2021 Sep; 10(1):54. PubMed ID: 34517920
[TBL] [Abstract][Full Text] [Related]
5. Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases.
Crum T; Mooney K; Tiwari BR
F1000Res; 2021; 10():652. PubMed ID: 35035888
[No Abstract] [Full Text] [Related]
6. No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
Halabi S; Heinrich A; Omer SB
N Engl J Med; 2020 Dec; 383(23):e125. PubMed ID: 33113309
[No Abstract] [Full Text] [Related]
7. Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.
Yuji K; Nakada H
Hum Vaccin Immunother; 2016 May; 12(5):1321-4. PubMed ID: 26513303
[TBL] [Abstract][Full Text] [Related]
8. How to ensure vaccine safety: An evaluation of China's vaccine regulation system.
Feng J; Li Q
Vaccine; 2021 Aug; 39(37):5285-5294. PubMed ID: 34373122
[TBL] [Abstract][Full Text] [Related]
9. The National Vaccine Injury Compensation Program.
Cook KM; Evans G
Pediatrics; 2011 May; 127 Suppl 1():S74-7. PubMed ID: 21502255
[TBL] [Abstract][Full Text] [Related]
10. "First Do No Harm". No-Fault Compensation Program for COVID-19 Vaccines as Feasibility and Wisdom of a Policy Instrument to Mitigate Vaccine Hesitancy.
D'Errico S; Zanon M; Concato M; Peruch M; Scopetti M; Frati P; Fineschi V
Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696224
[TBL] [Abstract][Full Text] [Related]
11. Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries.
Mungwira RG; Guillard C; Saldaña A; Okabe N; Petousis-Harris H; Agbenu E; Rodewald L; Zuber PLF
PLoS One; 2020; 15(5):e0233334. PubMed ID: 32437376
[TBL] [Abstract][Full Text] [Related]
12. COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.
Mazur A; Benitez S; Chuffart-Finsterwald S; La Rotta R; Hampton LM
Vaccine; 2021 Dec; 39(49):7128-7130. PubMed ID: 34732277
[No Abstract] [Full Text] [Related]
13. A Viral Pandemic, Vaccine Safety, and Compensation for Adverse Events.
Meissner HC
JAMA; 2021 Feb; 325(8):721-722. PubMed ID: 33544127
[No Abstract] [Full Text] [Related]
14. Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.
Wang C; Huang N; Lu QB; Black S; Liang X; Cui F
Front Immunol; 2022; 13():956473. PubMed ID: 36248783
[TBL] [Abstract][Full Text] [Related]
15. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
16. Allergic reactions to Japanese encephalitis vaccine.
Plesner AM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccination in the mass vaccination center: clinical practice and effectiveness analysis.
Fan J; Zhu L; Wu X; Luo C; Huang A; Wang W
Front Public Health; 2023; 11():1072883. PubMed ID: 37397712
[TBL] [Abstract][Full Text] [Related]
18. Performance of the United States Vaccine Injury Compensation Program (VICP): 1988-2019.
Thompson KM; Orenstein WA; Hinman AR
Vaccine; 2020 Feb; 38(9):2136-2143. PubMed ID: 31982259
[TBL] [Abstract][Full Text] [Related]
19. Mandatory vaccination and no fault vaccine injury compensation schemes: An identification of country-level policies.
Attwell K; Drislane S; Leask J
Vaccine; 2019 May; 37(21):2843-2848. PubMed ID: 31000414
[TBL] [Abstract][Full Text] [Related]
20. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.
Eslait-Olaciregui S; Llinás-Caballero K; Patiño-Manjarrés D; Urbina-Ariza T; Cediel-Becerra JF; Domínguez-Domínguez CA
Ther Adv Drug Saf; 2023; 14():20420986231165674. PubMed ID: 37223456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
